Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
N-(levodopa) chitosan derivative based on click chemistry shows biological functionality in brain cells.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: Ortega-Fimbres, Olimpia1 (AUTHOR); Montiel-Herrera, Marcelino1 (AUTHOR); García-Villa, Denisse1 (AUTHOR); Pérez-Delgado, Jonathan1 (AUTHOR); Monge-Sanchez, Diana1 (AUTHOR); Fernández-Quiroz, Daniel2 (AUTHOR); de la Re-Vega, Enrique3 (AUTHOR); Molina-Domínguez, Claudia3 (AUTHOR); Angulo-Molina, Aracely4 (AUTHOR); Castillo-Martín del Campo, Claudia5 (AUTHOR); Argüelles-Monal, Waldo6 (AUTHOR); Astiazaran-García, Humberto6 (AUTHOR); Preciado-Saldaña, Alejandra6 (AUTHOR); Domínguez-Ávila, Abraham6 (AUTHOR); González-Aguilar, Gustavo6 (AUTHOR)
- المصدر:
Drug Development & Industrial Pharmacy. Jul2023, Vol. 49 Issue 7, p439-447. 9p.
- الموضوع:
- معلومة اضافية
- نبذة مختصرة :
To develop N-(levodopa) chitosan derivatives through click chemistry to study their effect in brain cells. Significance: This study presents a proof-of-concept that macromolecules such as N-(Levodopa) chitosan derivatives traverse brain cell membranes and induce biomedical functionalities. Through click chemistry, we developed N-(levodopa) chitosan derivatives. They were physically and chemically characterized by FT-IR, 1H-NMR, TGA and Dynamic Light Scattering analyses. Solution and nanoparticles of N-(levodopa) chitosan derivatives were tested in primary cell cultures from the postnatal rat olfactory bulb, substantia nigra and corpus callosum. Ca2+ imaging and UPLC experiments were used to investigate if the biomaterial modulated the brain cell physiology. N-(levodopa) chitosan derivatives induced intracellular Ca2+ responses in primary cell cultures of the rat brain. UPLC experiments indicated that levodopa attached to chitosan was converted into dopamine by brain cells. The present study shows that N-(levodopa) chitosan may be useful to develop new treatment strategies, which could serve as molecular reservoirs of biomedical drugs to treat degenerative disorders of the nervous system. Parkinson's disease is a neurodegenerative disorder currently leading to several disabilities worldwide. We addressed this, by developing N-(levodopa) chitosan derivatives through green click chemistry to study their capabilities as dopamine precursors for brain cells. Interestingly, we found that in primary cell cultures and brain tissue of the postnatal rat, these chitosan derivatives (solution & nanoparticles) were homogeneously distributed inside of cells' membranes associated with intracellular Ca2+ responses. Therefore, N-(levodopa) chitosan may be useful as molecular reservoir of drugs to treat degenerative disorders of the nervous system. [ABSTRACT FROM AUTHOR]
- نبذة مختصرة :
Copyright of Drug Development & Industrial Pharmacy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.